首页 > 最新文献

Journal of Osteopathic Medicine最新文献

英文 中文
Osteopathic manipulative treatment for enhanced pitch performance in collegiate baseball players: a feasibility study on shoulder and hip interventions. 骨科手法治疗提高大学棒球运动员投球表现:肩部和髋关节干预的可行性研究。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-28 DOI: 10.1515/jom-2025-0106
Carissa Rosten, Sidney Brown, Tanaya Nandedkar, Alex Pearson, Ethan Worthington, Danielle Fastring
<p><strong>Context: </strong>Previous studies have sought to improve pitch performance and shoulder function utilizing the Muscle Energy Technique (MET) or Spencer's technique. The results of these studies have been mixed. Some found immediate, but short-lived, improvement to different planes of the range of motion (ROM) of the throwing shoulder. None found improved velocity or investigated further pitch metrics, such as spin rate.</p><p><strong>Objectives: </strong>This study is the first to measure the effects of osteopathic manipulative treatment (OMT) among key points of the kinetic chain, measuring ROM of the shoulder and the hip, as well as pitch metrics beyond release velocity.</p><p><strong>Methods: </strong>Baseball pitchers from a local collegiate baseball team were offered participation in this study. Pitchers had to be medically cleared for participation as members of the team and had to be given permission by the coach to join the study. Sixteen pitchers were assessed for inclusion, and 13 of the 16 were randomized into OMT and control groups for a prospective cohort study. One dropped out of the control group upon randomization, and one member of the control broke baseline protocol, leaving six members in the experimental group, and five members in the control group. Data, including pitch metrics, active ROM, and demographics were collected at three time points with statistical analyses comparing data between groups. Kerlan-Jobe Orthopaedic Clinic Shoulder and Elbow Score (KJOC-SES) was collected twice. After the third time point, the control group was crossed over to receive the OMT protocol also. Data were analyzed utilizing paired <i>t</i>-tests and Fisher's exact test.</p><p><strong>Results: </strong>Six pitchers received intervention (OMT), and five pitchers received no intervention (control). Overuse injuries developed in the control group only, preventing two of the five members of the control group from throwing further pitches for data collection at 5 weeks. When analyzed by Fisher's exact test, those in the control group were 9.29 times more likely to develop an injury than those receiving a single application of OMT. The only significant difference in pitch performance was an immediate 0.74 mph reduction in effective velocity in the OMT group (p=0.048), not sustained at the 5-week follow-up. Immediately posttreatment, the intervention group appreciated a 7.16° advantage in shoulder internal rotation over the control group (p=0.017). Five weeks posttreatment, the intervention group appreciated a 9.44° advantage in shoulder external rotation (p=0.047). Bilateral hip extension was immediately significantly improved in the treatment group (p<0.001). Left hip flexion was significantly improved in the treatment group when compared against the control group both immediately by 6.76° (p<0.011) and at 5-week follow-up by 12.87° (p<0.001). An advantage in right hip flexion was significant only at 5 weeks by 5.89° (p<0.02).</p><p><s
背景:先前的研究试图利用肌肉能量技术(MET)或斯宾塞技术来改善投球表现和肩部功能。这些研究的结果好坏参半。有些人发现投掷肩的不同平面活动范围(ROM)得到了立即但短暂的改善。没有人发现速度有所提高,也没有人研究进一步的俯仰指标,比如旋转速率。目的:本研究首次测量骨疗法手法治疗(OMT)对动力链关键点的影响,测量肩部和髋关节的ROM以及释放速度以外的pitch指标。方法:选取当地某大学棒球队的投手为研究对象。投手必须经过医学检查才能作为球队成员参加,并且必须得到教练的许可才能参加研究。16名投手被评估纳入,16名投手中的13名被随机分为OMT组和对照组,进行前瞻性队列研究。随机分组后,1人退出对照组,1人违反基线协议,实验组6人,对照组5人。在三个时间点收集数据,包括音调指标、活动ROM和人口统计数据,并对组间数据进行统计分析比较。采集Kerlan-Jobe骨科临床肩肘评分(KJOC-SES) 2次。在第三个时间点之后,对照组也被交叉接受OMT协议。数据分析采用配对t检验和Fisher精确检验。结果:6名投手接受干预(OMT), 5名投手不接受干预(对照组)。只有对照组出现了过度使用损伤,在5 周时,对照组的5名成员中有2名无法继续投球以收集数据。通过Fisher的精确测试分析,对照组的人受伤的可能性是接受单次OMT的人的9.29倍。在音高表现上的唯一显著差异是OMT组的有效速度立即降低0.74 mph (p=0.048),在5周的随访中没有持续。治疗后,干预组的肩关节内旋度比对照组高7.16°(p=0.017)。治疗5周后,干预组肩关节外旋角度增加了9.44°(p=0.047)。结论:单次应用OMT是一种低风险的干预措施,可预防优秀顶球运动员的过度使用损伤。虽然这项研究发现了速度、ROM和受伤风险的差异,但这项研究受到样本量的限制(n=11)。需要更大的样本组来进行再现性和评估其他音高参数,如水平断裂、垂直断裂和音高延伸。
{"title":"Osteopathic manipulative treatment for enhanced pitch performance in collegiate baseball players: a feasibility study on shoulder and hip interventions.","authors":"Carissa Rosten, Sidney Brown, Tanaya Nandedkar, Alex Pearson, Ethan Worthington, Danielle Fastring","doi":"10.1515/jom-2025-0106","DOIUrl":"https://doi.org/10.1515/jom-2025-0106","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Context: &lt;/strong&gt;Previous studies have sought to improve pitch performance and shoulder function utilizing the Muscle Energy Technique (MET) or Spencer's technique. The results of these studies have been mixed. Some found immediate, but short-lived, improvement to different planes of the range of motion (ROM) of the throwing shoulder. None found improved velocity or investigated further pitch metrics, such as spin rate.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;This study is the first to measure the effects of osteopathic manipulative treatment (OMT) among key points of the kinetic chain, measuring ROM of the shoulder and the hip, as well as pitch metrics beyond release velocity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Baseball pitchers from a local collegiate baseball team were offered participation in this study. Pitchers had to be medically cleared for participation as members of the team and had to be given permission by the coach to join the study. Sixteen pitchers were assessed for inclusion, and 13 of the 16 were randomized into OMT and control groups for a prospective cohort study. One dropped out of the control group upon randomization, and one member of the control broke baseline protocol, leaving six members in the experimental group, and five members in the control group. Data, including pitch metrics, active ROM, and demographics were collected at three time points with statistical analyses comparing data between groups. Kerlan-Jobe Orthopaedic Clinic Shoulder and Elbow Score (KJOC-SES) was collected twice. After the third time point, the control group was crossed over to receive the OMT protocol also. Data were analyzed utilizing paired &lt;i&gt;t&lt;/i&gt;-tests and Fisher's exact test.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Six pitchers received intervention (OMT), and five pitchers received no intervention (control). Overuse injuries developed in the control group only, preventing two of the five members of the control group from throwing further pitches for data collection at 5 weeks. When analyzed by Fisher's exact test, those in the control group were 9.29 times more likely to develop an injury than those receiving a single application of OMT. The only significant difference in pitch performance was an immediate 0.74 mph reduction in effective velocity in the OMT group (p=0.048), not sustained at the 5-week follow-up. Immediately posttreatment, the intervention group appreciated a 7.16° advantage in shoulder internal rotation over the control group (p=0.017). Five weeks posttreatment, the intervention group appreciated a 9.44° advantage in shoulder external rotation (p=0.047). Bilateral hip extension was immediately significantly improved in the treatment group (p&lt;0.001). Left hip flexion was significantly improved in the treatment group when compared against the control group both immediately by 6.76° (p&lt;0.011) and at 5-week follow-up by 12.87° (p&lt;0.001). An advantage in right hip flexion was significant only at 5 weeks by 5.89° (p&lt;0.02).&lt;/p&gt;&lt;p&gt;&lt;s","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146053690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early osteopathic treatment delivered to patients with an acute lateral ankle sprain improves recovery: an investigative study. 对急性踝关节外侧扭伤患者进行早期整骨疗法治疗可改善康复:一项调查研究。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-22 DOI: 10.1515/jom-2025-0096
Claire Bournon, Dominique Prin-Conti, Jimmy Douay, Pierre-Alexandre Montfajon, Lukshe Kanagaratnam, Stéphane Gennai

Context: Acute lateral ankle sprain (ALAS) is responsible for short-term disability, increased risk for future acute ankle sprain, and chronic ankle instability. Several studies highlighted that manipulative therapy may reduce pain and increase the range of motion (ROM) of the injured ankle, but not all of them targeted acute injuries. Some studies focused their interest on a specific manipulative technique or utilized either physiotherapy or chiropractic techniques.

Objectives: The objectives of this study were to evaluate the effectiveness of osteopathic care in ALAS, to assess pain, edema, and functional stability of the injured ankle, and to assess and comparing mobility between the injured and noninjured ankle.

Methods: We conducted an interventional randomized controlled trial (RCT) in the emergency department (ED) of a French University Hospital. Fifty patients were enrolled in this study. They had to be ≥18 years old, consulting in the ED for a single ALAS (<72 h) stage 1 or 2, and must have had preliminary consultation with an emergency physician. Patients with an ALAS stage 3 or fractured, or with history of homolateral ankle surgery, were excluded. Patients were randomized either in the medical treatment (MT) group or in the medical and osteopathic treatment (MOT) group and had a 3-week follow-up. In the MOT group, the intervention consisted of a single osteopathic treatment (manual intervention) at Day 0, depending on the tissue affected and on the intensity of the tissular tension found, and individualized advice provided at Days 0, 7, and 21. Comparisons between groups were investigated utilizing the chi-square or Fisher's exact test, or Student's t-test or Mann Whitney U-test, as appropriate.

Results: Forty-five patients completed the study. The patients' median age was 29.5 years old (23-40 years). At Day 21, 95.7 % of patients in the MOT group had equivalent capacity of unloaded dorsal flexion between the injured and noninjured ankle, vs. 50.0 % of patients in the MT group (p=0.0005). Between Day 0 and Day 21, the pain with the injured ankle loaded and unloaded decreased more significantly in the MOT group (p=0.001 and p=0.0007, respectively), while the loaded and unloaded dorsal flexion, and the unloaded plantar flexion, increased (p=0.003, p<0.0001 and p=0.02, respectively). Between Day 0 and Day 0 postosteopathic treatment, all judgment criteria showed improvement in the MOT group. At Day 7, all the functional stability tests were performed better by patients in the MOT group.

Conclusions: Early osteopathic treatment associated with usual MT, delivered to patients with an ALAS, may improve mobility and functional stability, and may reduce pain and edema, in the 3 weeks postintervention. These promising findings require confirmation in a larger controlled trial.

背景:急性外侧踝关节扭伤(ALAS)可导致短期残疾,增加未来急性踝关节扭伤的风险,以及慢性踝关节不稳定。一些研究强调,手法疗法可以减轻疼痛并增加受伤踝关节的活动范围(ROM),但并非所有的研究都针对急性损伤。一些研究将他们的兴趣集中在特定的操作技术上,或者利用物理疗法或脊椎按摩技术。目的:本研究的目的是评估骨科治疗的有效性,评估受伤踝关节的疼痛、水肿和功能稳定性,评估和比较受伤和未受伤踝关节的活动能力。方法:我们在法国大学附属医院急诊科进行了一项介入性随机对照试验(RCT)。50名患者参加了这项研究。他们必须年龄≥18岁,在急诊科咨询单个ALAS (t检验或Mann Whitney u检验,视情况而定)。结果:45例患者完成了研究。患者年龄中位数为29.5岁(23-40岁)。在第21天,95.7 %的MOT组患者在受伤和未受伤的踝关节之间具有相同的无负荷背屈能力,而MT组患者为50.0% % (p=0.0005)。在第0天至第21天,MOT组受伤踝关节负重和卸载时疼痛的减轻更为显著(p=0.001和p=0.0007),而负重和卸载的背屈曲和卸载的足底屈曲则增加(p=0.003)。结论:在干预后3周,对ALAS患者进行常规MT相关的早期骨科治疗可改善活动能力和功能稳定性,并可减轻疼痛和水肿。这些有希望的发现需要在更大的对照试验中得到证实。
{"title":"Early osteopathic treatment delivered to patients with an acute lateral ankle sprain improves recovery: an investigative study.","authors":"Claire Bournon, Dominique Prin-Conti, Jimmy Douay, Pierre-Alexandre Montfajon, Lukshe Kanagaratnam, Stéphane Gennai","doi":"10.1515/jom-2025-0096","DOIUrl":"https://doi.org/10.1515/jom-2025-0096","url":null,"abstract":"<p><strong>Context: </strong>Acute lateral ankle sprain (ALAS) is responsible for short-term disability, increased risk for future acute ankle sprain, and chronic ankle instability. Several studies highlighted that manipulative therapy may reduce pain and increase the range of motion (ROM) of the injured ankle, but not all of them targeted acute injuries. Some studies focused their interest on a specific manipulative technique or utilized either physiotherapy or chiropractic techniques.</p><p><strong>Objectives: </strong>The objectives of this study were to evaluate the effectiveness of osteopathic care in ALAS, to assess pain, edema, and functional stability of the injured ankle, and to assess and comparing mobility between the injured and noninjured ankle.</p><p><strong>Methods: </strong>We conducted an interventional randomized controlled trial (RCT) in the emergency department (ED) of a French University Hospital. Fifty patients were enrolled in this study. They had to be ≥18 years old, consulting in the ED for a single ALAS (<72 h) stage 1 or 2, and must have had preliminary consultation with an emergency physician. Patients with an ALAS stage 3 or fractured, or with history of homolateral ankle surgery, were excluded. Patients were randomized either in the medical treatment (MT) group or in the medical and osteopathic treatment (MOT) group and had a 3-week follow-up. In the MOT group, the intervention consisted of a single osteopathic treatment (manual intervention) at Day 0, depending on the tissue affected and on the intensity of the tissular tension found, and individualized advice provided at Days 0, 7, and 21. Comparisons between groups were investigated utilizing the chi-square or Fisher's exact test, or Student's <i>t</i>-test or Mann Whitney U-test, as appropriate.</p><p><strong>Results: </strong>Forty-five patients completed the study. The patients' median age was 29.5 years old (23-40 years). At Day 21, 95.7 % of patients in the MOT group had equivalent capacity of unloaded dorsal flexion between the injured and noninjured ankle, vs. 50.0 % of patients in the MT group (p=0.0005). Between Day 0 and Day 21, the pain with the injured ankle loaded and unloaded decreased more significantly in the MOT group (p=0.001 and p=0.0007, respectively), while the loaded and unloaded dorsal flexion, and the unloaded plantar flexion, increased (p=0.003, p<0.0001 and p=0.02, respectively). Between Day 0 and Day 0 postosteopathic treatment, all judgment criteria showed improvement in the MOT group. At Day 7, all the functional stability tests were performed better by patients in the MOT group.</p><p><strong>Conclusions: </strong>Early osteopathic treatment associated with usual MT, delivered to patients with an ALAS, may improve mobility and functional stability, and may reduce pain and edema, in the 3 weeks postintervention. These promising findings require confirmation in a larger controlled trial.</p>","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteopathic manipulative medicine among injured emergency department patients: a nationwide study. 骨科手法治疗在受伤急诊科病人中的应用:一项全国性的研究。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-19 DOI: 10.1515/jom-2025-0184
Hanna Harris, Aviya DiStefano, Kaitlin M Bowers, Dhimitri A Nikolla

Context: Osteopathic manipulative treatment (OMT) encompasses a wide range of diagnostic and treatment techniques for many conditions, but few studies have evaluated OMT use on injured patients.

Objectives: We aimed to describe the use of OMT on injured patients from a nationwide sample of emergency department (ED) encounters.

Methods: We performed a retrospective analysis of the 2018-2022 Nationwide Emergency Department Sample (NEDS) datasets. We included all ED encounters with an injury diagnosis as well as an osteopathic diagnosis or treatment, including International Classification of Diseases - Tenth Revision (ICD-10) Clinical Modification (CM) codes M9900-M9909, ICD-10 Procedure Coding System (PCS) codes 7W00X07-7W09X9Z, and Current Procedural Terminology/Healthcare Common Procedure Coding System (CPT/HCPCS) codes 98925-98929. We calculated the Injury Severity Score (ISS) and the predicted probability of injury-related in-hospital mortality for each encounter utilizing the ROCmax method. Except for counts, all statistics at the encounter level are weighted to account for the complex survey design.

Results: Among 29,966,447 ED encounters with an injury diagnosis within the study period, we identified 1,686 with at least one osteopathic diagnosis or treatment code, 6.0 per 100k injury encounters (95 % confidence interval [CI] 4.2 to 8.2). A minority of encounters (574 [35.5 %]) were at level 1 or 2 trauma centers. Although 677 (39.7 %) were admitted, the median ISS was only 1 (interquartile range [IQR 1, 4]), and only 62 (2.9 %) had computed tomography (CT) orders. The predicted probability of injury-related mortality was low, 1.5 % (IQR 1.3, 2.0). Most encounters had a somatic dysfunction diagnosis without an osteopathic treatment code, 1,239 (75.9 %). The most common site of injury, as well as the body area with somatic dysfunction diagnosis and osteopathic treatment, was the thorax.

Conclusions: In this nationwide sample, few injured ED patients received OMT, the majority only received a somatic dysfunction diagnosis without osteopathic treatment, and most had minor injuries. These results offer real-world insights into the use of OMT among injured ED patients and may inform efforts to promote its adoption.

背景:整骨疗法手法治疗(OMT)涵盖了许多疾病的广泛诊断和治疗技术,但很少有研究评估OMT在受伤患者中的应用。目的:我们旨在描述OMT在全国急诊科(ED)遭遇的受伤患者中的应用。方法:我们对2018-2022年全国急诊科样本(NEDS)数据集进行回顾性分析。我们纳入了所有有损伤诊断和骨科诊断或治疗的ED病例,包括国际疾病分类第十版(ICD-10)临床修改(CM)代码M9900-M9909, ICD-10程序编码系统(PCS)代码7W00X07-7W09X9Z,以及现行程序术语/医疗保健通用程序编码系统(CPT/HCPCS)代码98925-98929。我们利用ROCmax方法计算了每次遭遇的伤害严重性评分(ISS)和与伤害相关的住院死亡率的预测概率。除了计数外,所有接触水平的统计数据都被加权,以解释复杂的调查设计。结果:在研究期间29,966,447例ED损伤诊断中,我们确定了1,686例至少有一种骨科诊断或治疗代码,每100k例损伤中有6.0例(95 %置信区间[CI] 4.2至8.2)。少数患者(574例[35.5% %])在1级或2级创伤中心。虽然有677例(39.7 %)入院,但ISS的中位数仅为1(四分位间距[IQR 1,4]),只有62例(2.9 %)接受了CT检查。损伤相关死亡的预测概率较低,为1.5 % (IQR为1.3,2.0)。大多数患者在没有骨科治疗代码的情况下诊断为躯体功能障碍,1,239人(75.9% %)。最常见的损伤部位,以及有躯体功能障碍诊断和骨科治疗的身体部位是胸部。结论:在这个全国性的样本中,受伤的ED患者很少接受OMT治疗,大多数患者只接受了躯体功能障碍诊断,没有接受骨科治疗,大多数患者有轻微损伤。这些结果为在受伤的ED患者中使用OMT提供了真实的见解,并可能为促进其采用提供信息。
{"title":"Osteopathic manipulative medicine among injured emergency department patients: a nationwide study.","authors":"Hanna Harris, Aviya DiStefano, Kaitlin M Bowers, Dhimitri A Nikolla","doi":"10.1515/jom-2025-0184","DOIUrl":"https://doi.org/10.1515/jom-2025-0184","url":null,"abstract":"<p><strong>Context: </strong>Osteopathic manipulative treatment (OMT) encompasses a wide range of diagnostic and treatment techniques for many conditions, but few studies have evaluated OMT use on injured patients.</p><p><strong>Objectives: </strong>We aimed to describe the use of OMT on injured patients from a nationwide sample of emergency department (ED) encounters.</p><p><strong>Methods: </strong>We performed a retrospective analysis of the 2018-2022 Nationwide Emergency Department Sample (NEDS) datasets. We included all ED encounters with an injury diagnosis as well as an osteopathic diagnosis or treatment, including International Classification of Diseases - Tenth Revision (ICD-10) Clinical Modification (CM) codes M9900-M9909, ICD-10 Procedure Coding System (PCS) codes 7W00X07-7W09X9Z, and Current Procedural Terminology/Healthcare Common Procedure Coding System (CPT/HCPCS) codes 98925-98929. We calculated the Injury Severity Score (ISS) and the predicted probability of injury-related in-hospital mortality for each encounter utilizing the ROCmax method. Except for counts, all statistics at the encounter level are weighted to account for the complex survey design.</p><p><strong>Results: </strong>Among 29,966,447 ED encounters with an injury diagnosis within the study period, we identified 1,686 with at least one osteopathic diagnosis or treatment code, 6.0 per 100k injury encounters (95 % confidence interval [CI] 4.2 to 8.2). A minority of encounters (574 [35.5 %]) were at level 1 or 2 trauma centers. Although 677 (39.7 %) were admitted, the median ISS was only 1 (interquartile range [IQR 1, 4]), and only 62 (2.9 %) had computed tomography (CT) orders. The predicted probability of injury-related mortality was low, 1.5 % (IQR 1.3, 2.0). Most encounters had a somatic dysfunction diagnosis without an osteopathic treatment code, 1,239 (75.9 %). The most common site of injury, as well as the body area with somatic dysfunction diagnosis and osteopathic treatment, was the thorax.</p><p><strong>Conclusions: </strong>In this nationwide sample, few injured ED patients received OMT, the majority only received a somatic dysfunction diagnosis without osteopathic treatment, and most had minor injuries. These results offer real-world insights into the use of OMT among injured ED patients and may inform efforts to promote its adoption.</p>","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the association between history of open chest or abdominal surgery and cardiovascular risks: an NHANES study, January 2007 - March 2020. 2007年1月至2020年3月的一项NHANES研究:胸腔或腹部开腹手术史与心血管风险之间的关系评估
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 DOI: 10.1515/jom-2025-0155
Alexander Olson, David L Coffman, Clipper F Young

Context: The clinical relationship between cardiovascular disease and deleterious surgical outcomes has been extensively examined; however, the relationship between cardiovascular risk and the association with major surgical interventions has yet to be examined at the population level. Previous use of National Health and Nutrition Examination Survey (NHANES) data has investigated the relationship between cardiometabolic risk and a history of bariatric surgery, suggesting that NHANES population data may be a useful tool to uncover a primary association and provide insight into subgroup effects.

Objectives: This study attempts to quantify the relationships between cardiovascular risk factors and the history of open-chest or abdominal surgery.

Methods: We analyzed de-identified NHANES data from January 2007 through March 2020 for US adults ≥20 years of age selected via stratified multistage sampling (participants with missing data were excluded; Institutional Review Board [IRB] not required). We extracted self-reported history of open-chest/abdominal surgery (binary), seven metabolic/cardiovascular biomarkers (hemoglobin A1c [HbA1c], low-density lipoprotein [LDL], triglycerides, total cholesterol, systolic/diastolic blood pressure [SBP/DBP], high-density lipoprotein [HDL]), and covariates (race/ethnicity, gender, education, insurance, income-to-poverty ratio). Associations were estimated as odds ratios (ORs) utilizing survey-weighted logistic regression in STATA 16 adjusted for all covariates (two-sided α=0.05), with subpopulation logistic models for subgroup analyses by HbA1c.

Results: The elevated HbA1c level was the only variable that was statistically significant, with an OR of 1.14 (95 % confidence interval [CI], 1.06-1.23). Secondary subgroup analyses demonstrated differential impacts: Non-Hispanic White, individuals without insurance, those with a lower income-to-poverty ratio, females, and individuals with less than a ninth-grade education or a high school/General Education Development (GED) equivalent were more likely to have a surgical history as HbA1c levels increased.

Conclusions: A significant association exists between elevated HbA1c levels and a history of open-chest or abdominal surgery. Specific subgroups are at greater risk and may be disproportionately affected by the downstream consequences of higher HbA1c levels.

背景:心血管疾病与有害手术结果之间的临床关系已被广泛研究;然而,心血管风险与大手术干预之间的关系尚未在人群水平上得到检验。先前使用国家健康与营养调查(NHANES)数据调查了心脏代谢风险与减肥手术史之间的关系,表明NHANES人口数据可能是揭示主要关联并深入了解亚组效应的有用工具。目的:本研究试图量化心血管危险因素与开胸或腹部手术史之间的关系。方法:我们分析了2007年1月至2020年3月通过分层多阶段抽样选择的美国≥20岁成年人的去识别NHANES数据(排除数据缺失的参与者;不需要机构审查委员会[IRB])。我们提取了自我报告的开胸/腹部手术史(二元)、7种代谢/心血管生物标志物(血红蛋白A1c [HbA1c]、低密度脂蛋白[LDL]、甘油三酯、总胆固醇、收缩压/舒张压[SBP/DBP]、高密度脂蛋白[HDL])和协变量(种族/民族、性别、教育程度、保险、收入与贫困比)。利用STATA 16中的调查加权logistic回归对所有协变量进行校正(双侧α=0.05),并使用亚种群logistic模型对HbA1c进行亚组分析,以比值比(or)估计相关关系。结果:HbA1c水平升高是唯一具有统计学意义的变量,OR为1.14(95 %置信区间[CI], 1.06-1.23)。次级亚组分析显示了不同的影响:非西班牙裔白人、没有保险的人、收入与贫困比较低的人、女性、教育程度低于九年级或高中/普通教育发展(GED)水平的人更有可能有手术史,因为HbA1c水平升高。结论:HbA1c水平升高与开胸或腹部手术史存在显著关联。特定亚组的风险更大,并且可能不成比例地受到较高HbA1c水平的下游后果的影响。
{"title":"Evaluation of the association between history of open chest or abdominal surgery and cardiovascular risks: an NHANES study, January 2007 - March 2020.","authors":"Alexander Olson, David L Coffman, Clipper F Young","doi":"10.1515/jom-2025-0155","DOIUrl":"https://doi.org/10.1515/jom-2025-0155","url":null,"abstract":"<p><strong>Context: </strong>The clinical relationship between cardiovascular disease and deleterious surgical outcomes has been extensively examined; however, the relationship between cardiovascular risk and the association with major surgical interventions has yet to be examined at the population level. Previous use of National Health and Nutrition Examination Survey (NHANES) data has investigated the relationship between cardiometabolic risk and a history of bariatric surgery, suggesting that NHANES population data may be a useful tool to uncover a primary association and provide insight into subgroup effects.</p><p><strong>Objectives: </strong>This study attempts to quantify the relationships between cardiovascular risk factors and the history of open-chest or abdominal surgery.</p><p><strong>Methods: </strong>We analyzed de-identified NHANES data from January 2007 through March 2020 for US adults ≥20 years of age selected via stratified multistage sampling (participants with missing data were excluded; Institutional Review Board [IRB] not required). We extracted self-reported history of open-chest/abdominal surgery (binary), seven metabolic/cardiovascular biomarkers (hemoglobin A<sub>1c</sub> [HbA<sub>1c</sub>], low-density lipoprotein [LDL], triglycerides, total cholesterol, systolic/diastolic blood pressure [SBP/DBP], high-density lipoprotein [HDL]), and covariates (race/ethnicity, gender, education, insurance, income-to-poverty ratio). Associations were estimated as odds ratios (ORs) utilizing survey-weighted logistic regression in STATA 16 adjusted for all covariates (two-sided α=0.05), with subpopulation logistic models for subgroup analyses by HbA<sub>1c</sub>.</p><p><strong>Results: </strong>The elevated HbA<sub>1c</sub> level was the only variable that was statistically significant, with an OR of 1.14 (95 % confidence interval [CI], 1.06-1.23). Secondary subgroup analyses demonstrated differential impacts: Non-Hispanic White, individuals without insurance, those with a lower income-to-poverty ratio, females, and individuals with less than a ninth-grade education or a high school/General Education Development (GED) equivalent were more likely to have a surgical history as HbA<sub>1c</sub> levels increased.</p><p><strong>Conclusions: </strong>A significant association exists between elevated HbA<sub>1c</sub> levels and a history of open-chest or abdominal surgery. Specific subgroups are at greater risk and may be disproportionately affected by the downstream consequences of higher HbA<sub>1c</sub> levels.</p>","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allopathic resident prevalence in orthopedic residency programs formerly accredited by the American Osteopathic Association during single accreditation. 对抗疗法住院医师在骨科住院医师项目中的流行程度,以前由美国骨科协会在单一认证期间认可。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-09 DOI: 10.1515/jom-2024-0062
Jett B Murray, George C Balazs, Mark R Speicher, Aaron A Olsen

Context: The finalization of the Single Accreditation System (SAS) in 2020 resulted in the combined residency training of both allopathic (MD) and osteopathic (DO) graduates and has raised concerns about residency position availability for DO applicants in competitive specialties.

Objectives: The purpose of this study was to evaluate formerly American Osteopathic Association (AOA) - accredited orthopaedic surgery programs to identify the prevalence of DO degrees among program directors and residents, and stratify the association of program geography, program director degree, and osteopathic recognition status on resident composition.

Methods: A retrospective review of formerly AOA orthopaedic surgery programs was performed. Database information, program websites, and social medial profiles were used to determine program director degree and degree of all residents during academic year 2023-2024. Osteopathic Recognition status and program location were recorded. Associations were analyzed using chi-square and Fisher's Exact Test.

Results: Of the 36 identified formerly AOA programs, 12 (33.3 %) had an MD program director. Among 561 residents in these programs, there were 43 MD residents. MD residents were more likely to train under an MD program director (p < 0.01). Programs with a DO program director were significantly more likely to train zero MD residents (p < 0.01). Programs located in the Midwest trained the highest proportion of DOs (97.2 %, p < 0.01). All 5 programs with Osteopathic Recognition were training zero MD residents during the study period.

Conclusions: The increase in MD leadership in formerly AOA-accredited programs and the associated increase of MD residents in those programs that has occurred since the advent of the Single Accreditation System should be of concern to osteopathic leadership, who are dedicated to matching well qualified DO graduates into increasingly competitive residency positions such as those in orthopaedic surgery.

背景:2020年单一认证系统(SAS)的最终确定导致了对抗疗法(MD)和骨科(DO)毕业生的联合住院医师培训,并引发了对竞争专业DO申请人住院医师职位可用性的担忧。目的:本研究的目的是评估美国骨科协会(AOA)认可的骨科外科项目,以确定项目主任和住院医生中DO学位的患病率,并对项目地理、项目主任学位和住院医生对骨科的认知状况进行分层。方法:回顾性回顾以前的AOA骨科手术方案进行。利用数据库信息、项目网站和社交媒体资料确定2023-2024学年所有居民的项目主任学位和学位。记录整骨疗法识别状态和程序位置。使用卡方检验和Fisher精确检验分析相关性。结果:在36个确定的原AOA项目中,12个(33.3%)有MD项目主任。在这些项目的561名住院医生中,有43名MD住院医生。住院医师更有可能在医学博士项目主任的指导下接受培训(p < 0.01)。有DO项目主任的项目更有可能培养出零医学博士住院医师(p < 0.01)。中西部地区培训的DOs比例最高(97.2%,p < 0.01)。在研究期间,所有5个骨科识别项目都没有培训医学博士住院医师。结论:自从单一认证系统出现以来,以前aoa认证项目中医学博士领导的增加以及这些项目中医学博士住院医师的相关增加应该引起骨科领导的关注,他们致力于将合格的DO毕业生匹配到竞争日益激烈的住院医师职位,如骨科外科。
{"title":"Allopathic resident prevalence in orthopedic residency programs formerly accredited by the American Osteopathic Association during single accreditation.","authors":"Jett B Murray, George C Balazs, Mark R Speicher, Aaron A Olsen","doi":"10.1515/jom-2024-0062","DOIUrl":"https://doi.org/10.1515/jom-2024-0062","url":null,"abstract":"<p><strong>Context: </strong>The finalization of the Single Accreditation System (SAS) in 2020 resulted in the combined residency training of both allopathic (MD) and osteopathic (DO) graduates and has raised concerns about residency position availability for DO applicants in competitive specialties.</p><p><strong>Objectives: </strong>The purpose of this study was to evaluate formerly American Osteopathic Association (AOA) - accredited orthopaedic surgery programs to identify the prevalence of DO degrees among program directors and residents, and stratify the association of program geography, program director degree, and osteopathic recognition status on resident composition.</p><p><strong>Methods: </strong>A retrospective review of formerly AOA orthopaedic surgery programs was performed. Database information, program websites, and social medial profiles were used to determine program director degree and degree of all residents during academic year 2023-2024. Osteopathic Recognition status and program location were recorded. Associations were analyzed using chi-square and Fisher's Exact Test.</p><p><strong>Results: </strong>Of the 36 identified formerly AOA programs, 12 (33.3 %) had an MD program director. Among 561 residents in these programs, there were 43 MD residents. MD residents were more likely to train under an MD program director (p < 0.01). Programs with a DO program director were significantly more likely to train zero MD residents (p < 0.01). Programs located in the Midwest trained the highest proportion of DOs (97.2 %, p < 0.01). All 5 programs with Osteopathic Recognition were training zero MD residents during the study period.</p><p><strong>Conclusions: </strong>The increase in MD leadership in formerly AOA-accredited programs and the associated increase of MD residents in those programs that has occurred since the advent of the Single Accreditation System should be of concern to osteopathic leadership, who are dedicated to matching well qualified DO graduates into increasingly competitive residency positions such as those in orthopaedic surgery.</p>","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating biomarkers associated with mortality in patients receiving VA-ECMO for cardiogenic shock: a systematic review. 研究与接受VA-ECMO治疗心源性休克患者死亡率相关的生物标志物:一项系统综述。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-09 DOI: 10.1515/jom-2025-0145
James Ramsarran, Thomas Albertson, Tyler Hoops, Darsh Patel, Andreas N Christy, Robert Joyner
<p><strong>Context: </strong>Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a life-sustaining therapy for severe refractory cardiogenic shock. Although VA-ECMO provides various degrees of cardiopulmonary support, mortality rates remain high. Serum biomarkers have potential to identify the rising risk of mortality in patients receiving ECMO, but evidence supporting their prognostic value is inconsistent.</p><p><strong>Objectives: </strong>This study aims to systematically investigate existing evidence on the relationship between biomarkers and mortality in adult patients with refractory cardiogenic shock undergoing VA-ECMO support.</p><p><strong>Methods: </strong>A systematic review was conducted conforming to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Analogous search strings were developed to complete a comprehensive literature search across multiple databases that included Embase, Scopus, PubMed, and Cumulative Index to Nursing and Allied Health Literature (CINAHL). Search limits include studies published in the last 5 years (>2018) and in the English language. The inclusion criteria were: all genders aged 18 and older being treated for cardiogenic shock with VA-ECMO and intra-ECMO biomarker data with corresponding mortality data. Biomarkers included in the criteria were: lactate, creatinine, bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), troponin, C-reactive protein (CRP), and white blood cell (WBC) count. Identified articles were included within the main findings after unanimous approval by all authors. The quality of the evidence was assessed systematically utilizing a standardized and validated checklist.</p><p><strong>Results: </strong>Our search yielded 1,033 studies, with 650 studies remaining after the removal of duplicates, leaving 538 studies to be screened for title and abstract study relevance. Subsequently, 112 studies remained for full-text review. Reasons for exclusion during full-text review include conference abstract, no mention of specific biomarkers, and wrong comparison of treatment modalities. Five studies remained for data extraction. Data gathered from five retrospective cohort studies reported a total of 589 patients supported by VA-ECMO following a diagnosis of cardiogenic shock, with the most common inciting factor being postcardiac surgery. Most patients were male. The age range for all participants was between 45 and 77 years. Common comorbidities include diabetes mellitus, hypertension, and vascular disease. Overall mortality was 59.9 % (353/589) based on survival to 30-day post-ECMO initiation or hospital discharge. In three of the studies, the patients in the survivor cohort had statistically significant lower intra-ECMO lactate levels compared to the non-survivors (p<0.01). One of the studies found statistically significant differences between survivors and non-survivors in the intra-ECMO values for serum lactate (p<0.001
背景:静脉-动脉体外膜氧合(VA-ECMO)是严重难治性心源性休克的一种维持生命的治疗方法。尽管VA-ECMO提供了不同程度的心肺支持,但死亡率仍然很高。血清生物标志物有可能识别接受ECMO患者死亡风险的上升,但支持其预后价值的证据并不一致。目的:本研究旨在系统地调查接受VA-ECMO支持的成人难治性心源性休克患者的生物标志物与死亡率之间的关系。方法:按照系统评价和荟萃分析首选报告项目(PRISMA) 2020指南进行系统评价。开发了类似的搜索字符串来完成跨多个数据库的综合文献搜索,包括Embase、Scopus、PubMed和护理和相关健康文献累积索引(CINAHL)。搜索范围包括最近5年(2018年之前)和英语发表的研究。纳入标准为:年龄在18岁及以上的所有性别,使用VA-ECMO和ecmo内生物标志物数据以及相应的死亡率数据治疗心源性休克。生物标志物包括:乳酸、肌酐、胆红素、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、肌钙蛋白、c反应蛋白(CRP)和白细胞(WBC)计数。经所有作者一致同意后,确定的文章被纳入主要研究结果。使用标准化和有效的检查表系统地评估证据的质量。结果:我们检索了1033项研究,在去除重复项后,还剩下650项研究,剩下538项研究需要筛选标题和摘要研究的相关性。随后,仍有112项研究有待全文综述。在全文综述中被排除的原因包括会议摘要、未提及特定生物标志物和错误的治疗方式比较。还有5项研究有待数据提取。来自5项回顾性队列研究的数据报告了589例诊断为心源性休克后采用VA-ECMO的患者,最常见的刺激因素是心脏手术后。大多数患者为男性。所有参与者的年龄范围在45岁到77岁之间。常见的合并症包括糖尿病、高血压和血管疾病。基于ecmo启动或出院后30天的生存率,总死亡率为59.9 %(353/589)。在其中三项研究中,与非幸存者相比,幸存者队列患者的ecmo内乳酸水平具有统计学意义上的显著降低(结论:血清乳酸是最用于评估死亡风险的生物标志物)。血清肌酐(Scr)、胆红素、谷丙转氨酶(AST)和谷丙转氨酶(ALT)在预测死亡率方面也具有重要意义,尽管它们没有像血清乳酸那样被广泛研究。未来的研究需要进一步研究Scr、胆红素、AST和ALT的使用,以更好地评估它们在诊断为心源性休克的VA-ECMO患者死亡率中的意义。进一步的研究还需要调查这些生物标志物的最低浓度及其与死亡率的关系,以便临床医生更好地预测患者在接受VA-ECMO时的死亡风险。
{"title":"Investigating biomarkers associated with mortality in patients receiving VA-ECMO for cardiogenic shock: a systematic review.","authors":"James Ramsarran, Thomas Albertson, Tyler Hoops, Darsh Patel, Andreas N Christy, Robert Joyner","doi":"10.1515/jom-2025-0145","DOIUrl":"https://doi.org/10.1515/jom-2025-0145","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Context: &lt;/strong&gt;Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a life-sustaining therapy for severe refractory cardiogenic shock. Although VA-ECMO provides various degrees of cardiopulmonary support, mortality rates remain high. Serum biomarkers have potential to identify the rising risk of mortality in patients receiving ECMO, but evidence supporting their prognostic value is inconsistent.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;This study aims to systematically investigate existing evidence on the relationship between biomarkers and mortality in adult patients with refractory cardiogenic shock undergoing VA-ECMO support.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A systematic review was conducted conforming to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Analogous search strings were developed to complete a comprehensive literature search across multiple databases that included Embase, Scopus, PubMed, and Cumulative Index to Nursing and Allied Health Literature (CINAHL). Search limits include studies published in the last 5 years (&gt;2018) and in the English language. The inclusion criteria were: all genders aged 18 and older being treated for cardiogenic shock with VA-ECMO and intra-ECMO biomarker data with corresponding mortality data. Biomarkers included in the criteria were: lactate, creatinine, bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), troponin, C-reactive protein (CRP), and white blood cell (WBC) count. Identified articles were included within the main findings after unanimous approval by all authors. The quality of the evidence was assessed systematically utilizing a standardized and validated checklist.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Our search yielded 1,033 studies, with 650 studies remaining after the removal of duplicates, leaving 538 studies to be screened for title and abstract study relevance. Subsequently, 112 studies remained for full-text review. Reasons for exclusion during full-text review include conference abstract, no mention of specific biomarkers, and wrong comparison of treatment modalities. Five studies remained for data extraction. Data gathered from five retrospective cohort studies reported a total of 589 patients supported by VA-ECMO following a diagnosis of cardiogenic shock, with the most common inciting factor being postcardiac surgery. Most patients were male. The age range for all participants was between 45 and 77 years. Common comorbidities include diabetes mellitus, hypertension, and vascular disease. Overall mortality was 59.9 % (353/589) based on survival to 30-day post-ECMO initiation or hospital discharge. In three of the studies, the patients in the survivor cohort had statistically significant lower intra-ECMO lactate levels compared to the non-survivors (p&lt;0.01). One of the studies found statistically significant differences between survivors and non-survivors in the intra-ECMO values for serum lactate (p&lt;0.001","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of COMLEX-USA Level 1 pass/fail score reporting on student stress, test preparation, and performance. complex - usa 1级及格/不及格分数报告对学生压力、考试准备和表现的影响。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-08 DOI: 10.1515/jom-2025-0032
Rong Jin, Jeanne M Sandella, Gretta A Gross, Mark Dawley, John Boulet, Xia Mao, Yi Wang

Context: The Comprehensive Osteopathic Medical Licensing Examination of the United States (COMLEX-USA) is a three-level national standardized licensure examination designed for the practice of osteopathic medicine. Following several years of analysis and considering input from across the continuum of osteopathic medical education, training, and licensure, the National Board of Osteopathic Medical Examiners (NBOME) transitioned COMLEX-USA Level 1 (Level 1) score reporting from a numeric score with a pass/fail result to a pass/fail result only beginning with the 2022-2023 testing cycle in May 2022.

Objectives: The purpose of this study is to investigate the differences in student Level 1 self-reported stress levels, test preparation, and performance following the transition to pass/fail score reporting.

Methods: The study utilized data from Level 1, including end-of-examination survey responses from first-time test takers in the 2023-2024 administration and examination performance data from first-time test takers across the 2021-2022, 2022-2023, and 2023-2024 administrations. The analysis examined changes in three key outcomes: self-reported stress during examination preparation, perceived examination preparation, and performance on Level 1 examination.

Results: After Level 1 transitioned to pass/fail score reporting, 60 % of students responding to the 2023-2024 end-of-examination survey reported reduced stress in Level 1 examination preparation, and 75 % of respondents reported no change in preparation time. In the first testing cycle after the transition, declines were observed in several performance indicators, including pass rate and the mean, standard deviation, and maximum of z-scores (converted from Level 1 numeric scores). In the subsequent cycle, the pass rate rebounded and the mean z-score stabilized, while both the standard deviation and maximum z-score continued to decline.

Conclusions: The COMLEX-USA series is designed as a licensure examination to assess competencies essential for the practice of osteopathic medicine. Passage of Level 1 indicates that a student has demonstrated competence in the foundational biomedical sciences, osteopathic principles, and related physician competency domains to enter supervised patient care settings. The transition in score reporting for Level 1 preserves that purpose. This study provides preliminary insights into the perceived differences in students' stress level, examination preparation, and examination performance patterns following the change of score reporting. Further study will be conducted as these students transition through their osteopathic education.

背景:美国综合骨科医师执照考试(complex - usa)是为骨科医学实践设计的三级国家标准化执照考试。经过几年的分析,并考虑了整个骨科医学教育、培训和许可连续体的输入,国家骨科医学检查委员会(nnbome)将复杂-美国1级(1级)分数报告从合格/不合格的数字分数转变为合格/不合格结果,仅从2022年5月的2022-2023测试周期开始。目的:本研究的目的是调查学生1级自我报告的压力水平、考试准备和表现在过渡到及格/不及格分数报告后的差异。方法:该研究使用了一级数据,包括2023-2024年期间首次参加考试的考生的考试结束调查反馈,以及2021-2022年、2022-2023年和2023-2024年期间首次参加考试的考生的考试成绩数据。分析考察了三个关键结果的变化:考试准备期间自我报告的压力、感知的考试准备和一级考试的表现。结果:在1级过渡到合格/不合格分数报告后,60% %的学生回应了2023-2024年的考试结束调查,他们表示1级考试准备的压力减轻了,75% %的受访者表示准备时间没有变化。在转换后的第一个测试周期中,在几个性能指标中观察到下降,包括通过率、平均值、标准差和z分数最大值(从1级数字分数转换)。在随后的周期中,通过率回升,平均z-score趋于稳定,而标准差和最大z-score继续下降。结论:complex - usa系列被设计为一种执照考试来评估骨科医学实践所必需的能力。通过1级表明学生在基础生物医学科学、整骨疗法原理和相关医师能力领域具有进入有监督的患者护理环境的能力。第1级的分数报告转换保留了这一目的。本研究对成绩报告改变后学生的压力水平、考试准备和考试表现模式的感知差异提供了初步的见解。当这些学生通过整骨疗法教育过渡时,将进行进一步的研究。
{"title":"Effect of COMLEX-USA Level 1 pass/fail score reporting on student stress, test preparation, and performance.","authors":"Rong Jin, Jeanne M Sandella, Gretta A Gross, Mark Dawley, John Boulet, Xia Mao, Yi Wang","doi":"10.1515/jom-2025-0032","DOIUrl":"https://doi.org/10.1515/jom-2025-0032","url":null,"abstract":"<p><strong>Context: </strong>The Comprehensive Osteopathic Medical Licensing Examination of the United States (COMLEX-USA) is a three-level national standardized licensure examination designed for the practice of osteopathic medicine. Following several years of analysis and considering input from across the continuum of osteopathic medical education, training, and licensure, the National Board of Osteopathic Medical Examiners (NBOME) transitioned COMLEX-USA Level 1 (Level 1) score reporting from a numeric score with a pass/fail result to a pass/fail result only beginning with the 2022-2023 testing cycle in May 2022.</p><p><strong>Objectives: </strong>The purpose of this study is to investigate the differences in student Level 1 self-reported stress levels, test preparation, and performance following the transition to pass/fail score reporting.</p><p><strong>Methods: </strong>The study utilized data from Level 1, including end-of-examination survey responses from first-time test takers in the 2023-2024 administration and examination performance data from first-time test takers across the 2021-2022, 2022-2023, and 2023-2024 administrations. The analysis examined changes in three key outcomes: self-reported stress during examination preparation, perceived examination preparation, and performance on Level 1 examination.</p><p><strong>Results: </strong>After Level 1 transitioned to pass/fail score reporting, 60 % of students responding to the 2023-2024 end-of-examination survey reported reduced stress in Level 1 examination preparation, and 75 % of respondents reported no change in preparation time. In the first testing cycle after the transition, declines were observed in several performance indicators, including pass rate and the mean, standard deviation, and maximum of z-scores (converted from Level 1 numeric scores). In the subsequent cycle, the pass rate rebounded and the mean z-score stabilized, while both the standard deviation and maximum z-score continued to decline.</p><p><strong>Conclusions: </strong>The COMLEX-USA series is designed as a licensure examination to assess competencies essential for the practice of osteopathic medicine. Passage of Level 1 indicates that a student has demonstrated competence in the foundational biomedical sciences, osteopathic principles, and related physician competency domains to enter supervised patient care settings. The transition in score reporting for Level 1 preserves that purpose. This study provides preliminary insights into the perceived differences in students' stress level, examination preparation, and examination performance patterns following the change of score reporting. Further study will be conducted as these students transition through their osteopathic education.</p>","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of hepatitis B immunity in vaccinated medical students. 接种乙肝疫苗医学生乙肝免疫分析。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-12 DOI: 10.1515/jom-2025-0005
Nicole Gentile, Chandni Aghera, Haylie Smith, Sena Mazzoleni, David Redden, Lindsay Tjiattas-Saleski
<p><strong>Context: </strong>Hepatitis B virus (HBV) is a vaccine-preventable hepatic infection causing transient and chronic infections, ultimately leading to liver failure with cirrhosis and hepatocellular carcinoma (HCC). Because healthcare workers and medical students are at higher exposure risk to this virus, immunity status is important to assess and maintain. Previous studies have shown a decrease in those classified as immune by antibody titer within the medical student and healthcare worker populations.</p><p><strong>Objectives: </strong>The objective of this study is to evaluate whether various factors, including the interval between vaccination and antibody titer measurement and the timing of first vaccination, contribute to a reduction in HBV immunity among medical students with a history of HBV vaccination.</p><p><strong>Methods: </strong>This retrospective cohort study utilized previously collected vaccination data from students who have attended or currently attend Edward Via College of Osteopathic Medicine's - Carolinas Campus (VCOM-Carolinas) from the years 2011 to 2023. The deidentified data include subjects' age, sex, original vaccination dates, HBV titer date, repeat vaccination dates and titer dates (if applicable), and final immunity status. Of the 2050 students, 1878 subjects met the study's criteria. Students are required to obtain the hepatitis B surface antibody titer prior to matriculation. A student was considered immune if his or her titers were over the lab-provided threshold or if otherwise nonimmune. Statistical analyze included sample mean, standard deviation (SD), and the Wilcoxon rank-sum test for continuous measures such as age at first vaccination, time since last dose, time between doses, and subject's age. Pearson's chi-square test compared the differences in nonimmunity rates by year, gender, and number of vaccine doses. A multivariable logistic regression model was utilized to determine which variables associated with nonimmunity remained statistically significant in the presence of each other.</p><p><strong>Results: </strong>The results show a significant decrease (p<0.001) in the population of students considered nonimmune to HBV, from 16.0 to 61.3 % in the classes from 2011 to 2023. There also was a statistically nonsignificant difference in nonimmunity rate by sex (females=39.9 %, males=38.3 %, p=0.50). There was a significant difference between the percentage of students who were nonimmune based upon the age at which they were first vaccinated. Although only 47.8 % of students who received their first vaccination at 5 years old or younger were nonimmune, only 11.3 % of students who received their first vaccination after 5 years of age were nonimmune (p<0.001). The odds of being nonimmune multiplied by 1.11 for each year postimmunization (p<0.001).</p><p><strong>Conclusions: </strong>Overall, the longer duration after immunization increases the odds that a person will have decreased immunity to HBV. Th
背景:乙型肝炎病毒(HBV)是一种疫苗可预防的肝脏感染,可引起短暂和慢性感染,最终导致肝功能衰竭伴肝硬化和肝细胞癌(HCC)。由于卫生保健工作者和医学生接触这种病毒的风险较高,因此评估和维持免疫状态很重要。先前的研究表明,在医学生和卫生保健工作者人群中,通过抗体滴度被分类为免疫的人减少。目的:本研究的目的是评估各种因素,包括接种疫苗和抗体滴度测定之间的间隔以及首次接种疫苗的时间,是否有助于降低有HBV疫苗接种史的医学生的HBV免疫力。方法:这项回顾性队列研究利用了2011年至2023年间曾就读或目前就读于爱德华维亚骨科医学院卡罗来纳分校(VCOM-Carolinas)的学生的疫苗接种数据。确定的数据包括受试者的年龄、性别、原始疫苗接种日期、HBV滴度日期、重复疫苗接种日期和滴度日期(如适用)以及最终免疫状态。在2050名学生中,有1878名符合研究标准。学生必须在入学前取得乙型肝炎表面抗体滴度。如果一个学生的滴度超过实验室提供的阈值,或者没有免疫,就被认为是免疫的。统计分析包括样本均值、标准差(SD)和连续测量的Wilcoxon秩和检验,如首次接种疫苗的年龄、上次接种的时间、两次接种的时间和受试者的年龄。皮尔逊卡方检验比较了不同年份、性别和疫苗剂量的非免疫率差异。使用多变量逻辑回归模型来确定哪些与非免疫相关的变量在彼此存在时仍然具有统计显著性。结论:总体而言,接种疫苗后时间越长,乙肝病毒免疫力下降的几率就越大。这项研究表明,那些感染HBV风险较高的人可能需要更定期地筛查他们的HBV滴度,并可能根据需要获得加强疫苗接种。
{"title":"Analysis of hepatitis B immunity in vaccinated medical students.","authors":"Nicole Gentile, Chandni Aghera, Haylie Smith, Sena Mazzoleni, David Redden, Lindsay Tjiattas-Saleski","doi":"10.1515/jom-2025-0005","DOIUrl":"https://doi.org/10.1515/jom-2025-0005","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Context: &lt;/strong&gt;Hepatitis B virus (HBV) is a vaccine-preventable hepatic infection causing transient and chronic infections, ultimately leading to liver failure with cirrhosis and hepatocellular carcinoma (HCC). Because healthcare workers and medical students are at higher exposure risk to this virus, immunity status is important to assess and maintain. Previous studies have shown a decrease in those classified as immune by antibody titer within the medical student and healthcare worker populations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The objective of this study is to evaluate whether various factors, including the interval between vaccination and antibody titer measurement and the timing of first vaccination, contribute to a reduction in HBV immunity among medical students with a history of HBV vaccination.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This retrospective cohort study utilized previously collected vaccination data from students who have attended or currently attend Edward Via College of Osteopathic Medicine's - Carolinas Campus (VCOM-Carolinas) from the years 2011 to 2023. The deidentified data include subjects' age, sex, original vaccination dates, HBV titer date, repeat vaccination dates and titer dates (if applicable), and final immunity status. Of the 2050 students, 1878 subjects met the study's criteria. Students are required to obtain the hepatitis B surface antibody titer prior to matriculation. A student was considered immune if his or her titers were over the lab-provided threshold or if otherwise nonimmune. Statistical analyze included sample mean, standard deviation (SD), and the Wilcoxon rank-sum test for continuous measures such as age at first vaccination, time since last dose, time between doses, and subject's age. Pearson's chi-square test compared the differences in nonimmunity rates by year, gender, and number of vaccine doses. A multivariable logistic regression model was utilized to determine which variables associated with nonimmunity remained statistically significant in the presence of each other.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The results show a significant decrease (p&lt;0.001) in the population of students considered nonimmune to HBV, from 16.0 to 61.3 % in the classes from 2011 to 2023. There also was a statistically nonsignificant difference in nonimmunity rate by sex (females=39.9 %, males=38.3 %, p=0.50). There was a significant difference between the percentage of students who were nonimmune based upon the age at which they were first vaccinated. Although only 47.8 % of students who received their first vaccination at 5 years old or younger were nonimmune, only 11.3 % of students who received their first vaccination after 5 years of age were nonimmune (p&lt;0.001). The odds of being nonimmune multiplied by 1.11 for each year postimmunization (p&lt;0.001).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Overall, the longer duration after immunization increases the odds that a person will have decreased immunity to HBV. Th","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145726098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of discontinuation and non-publishing of osteoporosis clinical trials. 中止和未发表骨质疏松症临床试验的影响。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-10 DOI: 10.1515/jom-2025-0183
Daxton Kennington, Andrew Simonsen, Whitney Shae, Catherine Satterwhite

Context: Osteoporosis is a prevalent chronic disease associated with fractures, reduced quality of life, and substantial healthcare costs. Randomized controlled trials (RCTs) are essential for developing effective treatments, but when trials are discontinued or unpublished, valuable data are lost. This results in unnecessary costs and exposes thousands of participants to interventions without contributing to clinical care.

Objectives: This study aims to evaluate the rates and characteristics of discontinuation and nonpublication among US-registered phase 3 and 4 RCTs investigating osteoporosis therapies from 2000 to 2022.

Methods: Phase 3 and 4 osteoporosis-related RCTs were identified through ClinicalTrials.gov. Trial completion and publication status were determined utilizing multiple databases and researcher contact. Chi-square and Fisher's exact tests assessed the associations between trial characteristics and outcomes.

Results: Of 303 trials, 29 (9.6 %) were discontinued, and 274 (90.4 %) completed. Among completed trials, 124 (45.3 %) remained unpublished. Discontinuation was significantly more common in nonindustry-funded and single-center trials (p<0.01, p=0.04). Nonpublication was more frequent among industry-funded and internationally recruited trials (p<0.01, p=0.01).

Conclusions: Nearly half of osteoporosis RCTs were either discontinued or unpublished, representing a substantial loss of clinical data, financial inefficiency, and ethical concerns. These findings mirror patterns observed in other therapeutic areas, underscoring systemic challenges in clinical research transparency. Strengthening feasibility assessments, enforcing reporting mandates, and addressing structural barriers to trial completion and publication are essential to safeguard research integrity and ensure that patient contributions meaningfully inform medical knowledge.

背景:骨质疏松症是一种与骨折、生活质量下降和大量医疗费用相关的普遍慢性疾病。随机对照试验(RCTs)对于开发有效的治疗方法至关重要,但当试验停止或未发表时,有价值的数据就会丢失。这导致了不必要的费用,并使成千上万的参与者暴露于干预措施中,而对临床护理没有贡献。目的:本研究旨在评估2000年至2022年在美国注册的研究骨质疏松症治疗的3期和4期随机对照试验的停药和不发表的比率和特征。方法:通过ClinicalTrials.gov网站筛选骨质疏松相关的3期和4期随机对照试验。利用多个数据库和研究者联系确定试验完成和发表状态。卡方检验和Fisher精确检验评估了试验特征和结果之间的关联。结果:在303项试验中,29项(9.6 %)终止,274项(90.4 %)完成。在完成的试验中,124项(45.3% %)未发表。结论:近一半的骨质疏松症随机对照试验要么停止,要么未发表,这意味着临床数据的大量丢失、财务效率低下和伦理问题。这些发现反映了在其他治疗领域观察到的模式,强调了临床研究透明度方面的系统性挑战。加强可行性评估,执行报告规定,解决试验完成和发表的结构性障碍,对于维护研究完整性和确保患者贡献有意义地为医学知识提供信息至关重要。
{"title":"The impact of discontinuation and non-publishing of osteoporosis clinical trials.","authors":"Daxton Kennington, Andrew Simonsen, Whitney Shae, Catherine Satterwhite","doi":"10.1515/jom-2025-0183","DOIUrl":"https://doi.org/10.1515/jom-2025-0183","url":null,"abstract":"<p><strong>Context: </strong>Osteoporosis is a prevalent chronic disease associated with fractures, reduced quality of life, and substantial healthcare costs. Randomized controlled trials (RCTs) are essential for developing effective treatments, but when trials are discontinued or unpublished, valuable data are lost. This results in unnecessary costs and exposes thousands of participants to interventions without contributing to clinical care.</p><p><strong>Objectives: </strong>This study aims to evaluate the rates and characteristics of discontinuation and nonpublication among US-registered phase 3 and 4 RCTs investigating osteoporosis therapies from 2000 to 2022.</p><p><strong>Methods: </strong>Phase 3 and 4 osteoporosis-related RCTs were identified through ClinicalTrials.gov. Trial completion and publication status were determined utilizing multiple databases and researcher contact. Chi-square and Fisher's exact tests assessed the associations between trial characteristics and outcomes.</p><p><strong>Results: </strong>Of 303 trials, 29 (9.6 %) were discontinued, and 274 (90.4 %) completed. Among completed trials, 124 (45.3 %) remained unpublished. Discontinuation was significantly more common in nonindustry-funded and single-center trials (p<0.01, p=0.04). Nonpublication was more frequent among industry-funded and internationally recruited trials (p<0.01, p=0.01).</p><p><strong>Conclusions: </strong>Nearly half of osteoporosis RCTs were either discontinued or unpublished, representing a substantial loss of clinical data, financial inefficiency, and ethical concerns. These findings mirror patterns observed in other therapeutic areas, underscoring systemic challenges in clinical research transparency. Strengthening feasibility assessments, enforcing reporting mandates, and addressing structural barriers to trial completion and publication are essential to safeguard research integrity and ensure that patient contributions meaningfully inform medical knowledge.</p>","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteopathic manipulative treatment for management of feeding dysfunction in breastfed newborns. 骨科手法治疗母乳喂养新生儿喂养功能障碍。
IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-08 DOI: 10.1515/jom-2024-0133
Dominique Fons, Kari Beth Watts, Holly Vannitamby, Shane Rainey, Jessica Ford-Davis, Yanzhi Wang, Seth Van Heukelom, Amanda Wright

Context: The benefits of breastfeeding are well established, from reduced incidence of common childhood infections to decreased incidence of sudden infant death syndrome and infant mortality. Offering support to breastfeeding mothers should be a key aspect of care in the perinatal period.

Objectives: The purpose of this study was to evaluate whether utilization of a standardized osteopathic manipulative treatment (OMT) protocol as an adjunct to lactation support improves feeding dysfunction in breastfed newborns.

Methods: This was a single-blinded, randomized, controlled, prospective pilot study of healthy, full-term neonates identified by an International Board Certified Lactation Consultant (IBCLC) as having feeding dysfunction. Neonates were subsequently randomized in an alternating fashion into an OMT protocol treatment vs. sham treatment. Infant LATCH (Latch, Audible swallowing, Type of nipple, Comfort of birth person, and Help birthing person needs holding infant to breast) scores were assessed by nurses and IBCLCs during hospitalization assessed with mean and median score improvement between groups.

Results: Forty infants were included in the study, divided into a sham group (n=21) and OMT group (n=19). The groups had similar characteristics. The change between pre- and postintervention LATCH scores were calculated for each group, respectively. The mean LATCH score change in the OMT group was 2.0±1.8. The mean LATCH score change in the sham group was 0.9±1.2. The mean LATCH score change in the OMT group is statistically significantly greater than the mean LATCH score change in the sham group (p=0.030), indicating that the OMT group had greater improvement in their LATCH score compared to the sham group.

Conclusions: Healthy newborns with feeding dysfunction who were randomized to receive two OMT treatments during their hospitalization demonstrated a statistically significant moderate improvement in the changes in the median modified LATCH score compared with newborns randomized to the sham group. However, the effect size was moderate, at best. The LATCH score changes between groups cannot be highly attributed to the OMT interventions. However, there were no adverse effects of treatment. These findings suggest that OMT may be a safe adjunct to traditional lactation support in the care of healthy breastfed newborns with feeding dysfunction. Future studies could investigate other factors, such as the length of time that mothers breastfeed their infants after the two initial treatment sessions or potentially including a separate arm for neonates with ankyloglossia.

背景:母乳喂养的好处是公认的,从降低儿童常见感染的发生率到降低婴儿猝死综合症和婴儿死亡率的发生率。为母乳喂养的母亲提供支持应该是围产期护理的一个关键方面。目的:本研究的目的是评估使用标准化骨科手法治疗(OMT)方案作为哺乳支持的辅助措施是否能改善母乳喂养新生儿的喂养功能障碍。方法:这是一项单盲、随机、对照、前瞻性的试点研究,研究对象是由国际委员会认证的哺乳顾问(IBCLC)确定为有喂养功能障碍的健康足月新生儿。随后,将新生儿随机分为OMT治疗组和假治疗组。住院期间由护士评估婴儿LATCH (LATCH, Audible吞咽,乳头类型,分娩人舒适度,帮助分娩人将婴儿抱到乳房)评分,ibclc评估组间平均和中位数评分改善。结果:40例婴儿纳入研究,分为假手术组(n=21)和OMT组(n=19)。这些群体具有相似的特征。分别计算各组干预前和干预后LATCH评分的变化。OMT组平均LATCH评分变化为2.0±1.8。假手术组的平均LATCH评分变化为0.9±1.2。OMT组的平均LATCH评分变化量显著大于假手术组的平均LATCH评分变化量(p=0.030),说明OMT组的LATCH评分比假手术组有更大的改善。结论:与随机分配到假手术组的新生儿相比,在住院期间随机接受两种OMT治疗的健康喂养功能障碍新生儿的中位修正LATCH评分的变化具有统计学显著的中度改善。然而,效应量充其量是中等的。各组间LATCH评分的变化不能高度归因于OMT干预。然而,没有不良反应的治疗。这些发现表明,OMT可能是一种安全的辅助传统哺乳支持护理母乳喂养功能障碍的健康新生儿。未来的研究可能会调查其他因素,比如母亲在两次初始治疗后母乳喂养婴儿的时间长度,或者可能为患有强直性咬合的新生儿提供单独的手臂。
{"title":"Osteopathic manipulative treatment for management of feeding dysfunction in breastfed newborns.","authors":"Dominique Fons, Kari Beth Watts, Holly Vannitamby, Shane Rainey, Jessica Ford-Davis, Yanzhi Wang, Seth Van Heukelom, Amanda Wright","doi":"10.1515/jom-2024-0133","DOIUrl":"https://doi.org/10.1515/jom-2024-0133","url":null,"abstract":"<p><strong>Context: </strong>The benefits of breastfeeding are well established, from reduced incidence of common childhood infections to decreased incidence of sudden infant death syndrome and infant mortality. Offering support to breastfeeding mothers should be a key aspect of care in the perinatal period.</p><p><strong>Objectives: </strong>The purpose of this study was to evaluate whether utilization of a standardized osteopathic manipulative treatment (OMT) protocol as an adjunct to lactation support improves feeding dysfunction in breastfed newborns.</p><p><strong>Methods: </strong>This was a single-blinded, randomized, controlled, prospective pilot study of healthy, full-term neonates identified by an International Board Certified Lactation Consultant (IBCLC) as having feeding dysfunction. Neonates were subsequently randomized in an alternating fashion into an OMT protocol treatment vs. sham treatment. Infant LATCH (<u>L</u>atch, <u>A</u>udible swallowing, <u>T</u>ype of nipple, <u>C</u>omfort of birth person, and <u>H</u>elp birthing person needs holding infant to breast) scores were assessed by nurses and IBCLCs during hospitalization assessed with mean and median score improvement between groups.</p><p><strong>Results: </strong>Forty infants were included in the study, divided into a sham group (n=21) and OMT group (n=19). The groups had similar characteristics. The change between pre- and postintervention LATCH scores were calculated for each group, respectively. The mean LATCH score change in the OMT group was 2.0±1.8. The mean LATCH score change in the sham group was 0.9±1.2. The mean LATCH score change in the OMT group is statistically significantly greater than the mean LATCH score change in the sham group (p=0.030), indicating that the OMT group had greater improvement in their LATCH score compared to the sham group.</p><p><strong>Conclusions: </strong>Healthy newborns with feeding dysfunction who were randomized to receive two OMT treatments during their hospitalization demonstrated a statistically significant moderate improvement in the changes in the median modified LATCH score compared with newborns randomized to the sham group. However, the effect size was moderate, at best. The LATCH score changes between groups cannot be highly attributed to the OMT interventions. However, there were no adverse effects of treatment. These findings suggest that OMT may be a safe adjunct to traditional lactation support in the care of healthy breastfed newborns with feeding dysfunction. Future studies could investigate other factors, such as the length of time that mothers breastfeed their infants after the two initial treatment sessions or potentially including a separate arm for neonates with ankyloglossia.</p>","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Osteopathic Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1